Oncology Institute (TOI) Net Cash Flow (2020 - 2026)

Oncology Institute (TOI) has 7 years of Net Cash Flow data on file, last reported at -$3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 66.92% year-over-year to -$3.3 million; the trailing twelve-month figure through Mar 2026 stood at -$9.5 million (down 370.41% YoY), and the FY2025 full-year result was -$16.1 million, down 199.52% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$3.3 million, down from $5.9 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $13.6 million in Q2 2023 and bottomed at -$47.4 million in Q4 2022.
• The 5-year median for Net Cash Flow is -$1.4 million (2023), against an average of -$5.0 million.
• The widest annual swing landed in 2024, when Net Cash Flow jumped 908.99%; it then plunged 2660.16% in 2025.
• A 5-year view of Net Cash Flow shows it stood at -$47.4 million in 2022, then jumped by 112.56% to $6.0 million in 2023, then sank by 65.04% to $2.1 million in 2024, then jumped by 183.85% to $5.9 million in 2025, then plunged by 155.61% to -$3.3 million in 2026.
• The last three Net Cash Flow figures came in at -$3.3 million (Q1 2026), $5.9 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.

Peer Comparison